ClinicalTrials.gg
RecruitingNCT07665242Updated Jul 9, 2026

Chatbot Intervention Effects on Social and Monetary Incentive Processing in Anhedonia

An interventional study of MI Chatbot Interaction and Active Control Chatbot Interaction in Healthy, sponsored by University of Electronic Science and Technology of China. Recruiting at 1 site in China. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by University of Electronic Science and Technology of China · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The main aim of the present study is to investigate the effects of a Motivational Interviewing-based artificial intelligence chatbot on social incentive processing in college students with elevated levels of depression and anhedonia by combining a randomized active-control intervention design with pre- and post-intervention Social Incentive Delay Task assessments during fMRI.

Read the detailed description

Anhedonia represents a core characteristic of depression and is characterized by reduced experience of pleasure. It is closely related to decreased motivation, altered reward processing, changes in affective responsiveness, and alterations in intrinsic brain network function. Anhedonia is not specifically targeted by currently available pharmacological interventions. Initial evidence indicates that an increased willingness to change and implementation of change in daily life can alleviate anhedonia.

The present study aims to examine whether a Motivational Interviewing-based AI chatbot can lead to changes in social incentive processing in college students with elevated anhedonia and depressive symptoms. Social incentive processing is included because social approval, social feedback, and interpersonal reward are important sources of motivation in daily life and may be altered in individuals with elevated anhedonia. The Social Incentive Delay Task allows the study to examine behavioral and neural responses during the anticipation and receipt of social incentives. To this end, eligible participants with a total score of 22 or higher on the Snaith-Hamilton Pleasure Scale and a score of 14 or higher on the Beck Depression Inventory will undergo a randomized, between-subjects, active-control intervention study. Participants will be assigned to either a Motivational Interviewing-based chatbot group or an active control chatbot group for 1 week. Pre- and post-intervention assessments will include self-report questionnaires and the Social Incentive Delay Task during functional magnetic resonance imaging to examine psychological, behavioral, and neural effects of the intervention.

02

Conditions studied

  • Healthy

Keywords

  • fMRI
  • AI Interaction
03

In context

Lead sponsor

University of Electronic Science and Technology of China is the lead sponsor of 112 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-40 years
  • Right-handed
  • Normal or corrected normal visual acuity
  • Participants must show elevated anhedonia and depressive symptoms at screening, defined as a total score of 22 or higher on the Snaith-Hamilton Pleasure Scale and a score of 14 or higher on the Beck Depression Inventory

Exclusion criteria

Exclusion Criteria:

  • History of major central nervous system disorders, such as epilepsy, traumatic brain injury, stroke, or brain tumors.
  • History of severe mental illness, including schizophrenia spectrum disorders, bipolar disorder, or other psychotic disorders.
  • History of substance or alcohol use disorder or substance or alcohol misuse within the past 12 months that may affect study participation or outcome assessment.
  • Individuals currently at high risk of suicide, severe self-harm, or experiencing an acute psychiatric crisis.
  • Individuals who are currently using psychiatric medications or have undergone psychotherapy within the past 4 weeks that may significantly affect mood, motivation, or reward processing.
  • Severe vision or hearing impairments that cannot be corrected and would interfere with task performance.
  • to MRI scanning, including metallic implants, pacemakers, severe claustrophobia, or other conditions incompatible with MRI.
  • Pregnancy or breastfeeding.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Motivational Interviewing-based AI chatbot group

    Motivational Interviewing-based AI chatbot intervention

    Behavioral: MI Chatbot Interaction

  • Active comparator
    Active control chatbot group

    Active control nature-story chatbot intervention

    Behavioral: Active Control Chatbot Interaction

Interventions

  • BehavioralMI Chatbot Interaction

    The experimental chatbot is designed to use principles of Motivational Interviewing to support participants in exploring their personal values, motivation for change, and daily behavioral goals related to pleasure, engagement, and reward-seeking. During the intervention period, participants will interact with the chatbot regularly through brief text-based conversations. The chatbot will provide empathic, non-judgmental responses, encourage reflection on current difficulties, and help participants identify small, feasible actions that may increase daily engagement and positive experiences. It will not provide diagnosis, crisis counseling, or medical treatment.

  • BehavioralActive Control Chatbot Interaction

    Participants will interact with a chatbot matched in format and frequency of use. This chatbot will provide neutral nature-related stories or general natural history content. It will be designed to maintain participant engagement while avoiding therapeutic techniques, motivational interviewing strategies, behavioral activation guidance, or personalized mental health advice. This active control condition will help control for nonspecific effects of chatbot interaction, attention, expectancy, and digital engagement.

06

What researchers measure

Primary outcomes

  1. Neural Activity During Social Incentive Anticipation

    Participants will undergo task-based BOLD fMRI while completing the Social Incentive Delay Task. Neural responses during the anticipation of social incentive cues will be compared with responses to neutral cues using a general linear model. Pre-to-post intervention changes will be evaluated from the resulting beta contrast estimates.

    Time frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.

  2. Neural Activity During Monetary Incentive Anticipation

    Task-based BOLD fMRI data will be acquired while participants perform the Monetary Incentive Delay Task. Neural responses associated with the anticipation of monetary reward and punishment will be estimated using a general linear model. Beta contrast estimates will be calculated for monetary reward versus neutral and monetary punishment versus neutral conditions. These estimates will be used to assess changes between baseline and post-intervention.

    Time frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.

Secondary outcomes

  1. Behavioral Responsiveness to Social Incentive Cues

    Reaction time, accuracy, and hit rate will be calculated separately for social incentive cue conditions and neutral cue conditions in the Social Incentive Delay Task before and after the intervention. Behavioral differences between social incentive and neutral cue conditions will also be derived and compared from baseline to post-intervention.

    Time frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.

  2. Behavioral responsiveness to monetary incentives

    The Monetary Incentive Delay Task will be administered before and after the intervention. Reaction time, accuracy, and hit rate will be extracted separately for monetary incentive cue conditions and neutral cue conditions, and changes in behavioral differences between monetary incentive and neutral cue conditions will be calculated.

    Time frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Corresponding individual level data will be made available upon request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2026; primary completion for Jun 2028, 24 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 17, 2026
First posted
Jun 24, 2026
StartEst.
Jun 20, 2026
Primary completionEst.
Jun 30, 2028
CompletionEst.
Dec 31, 2028
Last update
Jul 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07665242
Responsible party
Benjamin Becker (Professor, University of Electronic Science and Technology of China) — Principal investigator
First posted
Jun 24, 2026
Start date
Jun 20, 2026 (estimated)
Primary completion
Jun 30, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jul 9, 2026

Study contacts

Benjamin Becker, Dr
Contact
bbecker@hku.hk
(852) 3917-5097

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion